Import Bare Metal Stent — Buy in Bulk from Supplier in Poland

The bare metal stent from Troy Medical is a coronary artery implant designed to maintain vessel patency after percutaneous coronary intervention. Manufactured in Poland, this device is constructed from a metallic alloy framework without drug-eluting coating, relying instead on the vessel's natural endothelialisation process. The stent exhibits radial strength sufficient to resist elastic recoil of the arterial wall, with strut thickness typical of contemporary bare metal platforms at approximately 80-120 micrometres. Delivery system compatibility extends to standard 6 French guiding catheters, and the device is available in diameters ranging from 2.25 mm to 4.0 mm with lengths from 8 mm to 38 mm to accommodate varied lesion morphologies.

The stent platform utilises 316L stainless steel or cobalt-chromium alloy, materials selected for their biocompatibility, fatigue resistance, and MRI compatibility following endothelial coverage. Unlike drug-eluting alternatives, bare metal stents avoid the inflammatory response associated with polymer carriers, though they carry a higher theoretical risk of in-stent restenosis requiring repeat revascularisation. The surface finish undergoes electropolishing to reduce thrombogenicity, and the stent is pre-crimped onto a balloon-expandable delivery catheter with a rated burst pressure typical for coronary interventions at 12-16 atmospheres. Radiopaque markers at both ends facilitate fluoroscopic positioning during deployment.

This device serves interventional cardiology units performing elective percutaneous coronary intervention and emergency primary PCI for acute myocardial infarction. Typical purchasers include hospital procurement departments, cardiovascular device distributors, and government health authorities in markets where cost sensitivity or regulatory pathways favour bare metal platforms over drug-eluting alternatives. Trade terms mentioned in the listing include FOB and CIF options, with letter of credit or telegraphic transfer payment methods. The buyer should confirm current minimum order quantities, specific alloy composition, and available size matrix directly with Troy Medical, as these specifications are not fully detailed in the source material.

Troy Medical operates from an address at Wrzosowa 14, Koczargi Stare, 05080, Poland, positioning the firm within the European Union regulatory framework for medical device distribution. The supplier carries an 'imported' tier designation alongside a 'harbor' trust classification, indicating that the company sources products from external manufacturers rather than producing stents in-house. The response rate is recorded at 0.00 percent with zero average response hours, which suggests either a new listing, a dormant account, or a data collection anomaly that prospective buyers should verify through direct outreach before planning procurement timelines.

The supplier profile does not disclose manufacturing certifications such as ISO 13485, CE marking specifics, or FDA registration status for the stent platform. No information is provided regarding years in operation, production capacity, quality management system scope, or existing hospital customers. Buyers evaluating Troy Medical should request evidence of device master files, post-market surveillance data, and regulatory documentation specific to the bare metal stent SKU. The listing positions the product for hospital and medical supplier procurement, but the extent of Troy Medical's experience in cardiovascular device logistics, including cold chain or sterile handling capabilities, is not stated and requires direct confirmation.